Abstract
Prevalence of cardiovascular risk factors, target organ damage, and subclinical and symptomatic cardiovascular disease in a national population of patients with chronic myeloid leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have